9-cis-retinoic acid but not 4-(hydroxyphenyl)retinamide inhibits prostate intraepithelial neoplasia in noble rats

Cancer Research

Volumn 62, Issue 18, 2002, Pages 5178-5182

  Christov, Konstantin T ^a   Moon, Richard C ^b   Lantvit, Daniel D ^b   Boone, Charles W ^c   Steele, Vernon E ^c   Lubet, Ronald A ^c   Kelloff, Gary J ^c   Pezzuto, John M ^b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; ESTRADIOL; FENRETINIDE; RETINOID; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CANCER PREVENTION; CARCINOGENESIS; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE TUMOR; RAT; RAT STRAIN; TUMOR MODEL;

ANIMALS; ANTICARCINOGENIC AGENTS; BODY WEIGHT; ESTRADIOL; FENRETINIDE; MALE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RATS; TESTOSTERONE; TRETINOIN;

EID: 0037105655     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Chemoprevention of prostate cancer: Concepts and strategies
2. Anti-androgens and other hormonal therapies for prostate cancer
3. Chemoprevention of rat prostate carcinogenesis by 9-cis-retinoic acid
4. Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl)retinamide
5. Chemoprevention activity of tamoxifen, N-(4-hydroxyphenyl)retinamide, and the vitamin D analogue Ro24-5531 for androgen-promoted carcinomas of the rat seminal vesicle and prostate
6. Influence of N-methyl-N-nitrosourea, testosterone, and N-(4-hydroxyphenyl)-all-trans-retinamide on prostate cancer induction in Wistar-Unilever rats
7. Retinoids in cancer chemoprevention
8. 9-cis-retinoic acid is a high affinity ligand for the retinoid X receptor
9. The efficacy of 9-cis-retinoic acid in experimental models of cancer
10. Beyond tamoxifen: The retinoid X receptor-selective ligand LGDT1069 (TARGRETIN) causes complete regression of mammary carcinoma
11. Characterization of adenocarcinomas of the dorsolateral prostate induced in Wistar rats by N-methyl-N-nitrosourea. 7, 12-dimethylbenz(a)anthracene, and 3, 2'-dimethyl-4-aminobiphenyl, following sequential treatment with cyproterone acetate and testosterone propionate
12. Gross and microscopic pathology of induced prostatic complex tumors arising in Lobund-Wistar rats
13. Histogenesis of induced prostate and seminal vesicle carcinoma in Lobund-Wistar rats: A system for histological scoring and grading
14. Comparative aspects of development and structure of the prostate
15. The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration
16. Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats
17. Androgen-supported estrogen-enhanced epithelial proliferation in the prostates of intact Noble rats
18. Intraductal dysplasia: A pre-malignant lesion of the prostate
19. Phase II chemoprevention trial of oral fenretinide in patients at risk for adenocarcinoma of the prostate
20. Differences in the pharmacokinetic properties of orally administered all-trans retinoic acid and 9-cis-retinoic acid in the plasma of nude mice